Oxytocin effects in schizophrenia: Reconciling mixed findings and moving forward

Neuroscience and Biobehavioral Reviews
Ellen R Bradley, Joshua D Woolley

Abstract

Schizophrenia is a severe mental illness that causes major functional impairment. Current pharmacologic treatments are inadequate, particularly for addressing negative and cognitive symptoms of the disorder. Oxytocin, a neuropeptide known to moderate social behaviors, has been investigated as a potential therapeutic for schizophrenia in recent years. Results have been decidedly mixed, leading to controversy regarding oxytocin's utility. In this review, we outline several considerations for interpreting the extant literature and propose a focused agenda for future work that builds on the most compelling findings regarding oxytocin effects in schizophrenia to date. Specifically, we examine underlying causes of heterogeneity in randomized clinical trials (RCTs) conducted thus far and highlight the complexity of the human oxytocin system. We then review evidence of oxytocin's effects on specific deficits in schizophrenia, arguing for further study using objective, precise outcome measures in order to determine whether oxytocin has the potential to improve functional impairment in schizophrenia.

References

Jan 1, 1992·Archives of General Psychiatry·T H McGlashan, W S Fenton
Jan 1, 1992·Psychopharmacology·P PopikJ M van Ree
Jan 1, 1987·Schizophrenia Bulletin·S R KayL A Opler
Jun 1, 1985·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·T TakagiK Yamaji
Oct 1, 1994·The American Journal of Psychiatry·J D HegartyG Oepen
Jun 12, 1998·Nature·R AdolphsA R Damasio
Dec 9, 1998·Journal of Clinical and Experimental Neuropsychology·C RandolphT N Chase
Feb 10, 1999·Psychopharmacology·D Feifel, T Reza
Dec 10, 1999·Journal of Autism and Developmental Disorders·S Baron-CohenK Plaisted
Feb 29, 2000·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·B KirkpatrickW T Carpenter
Dec 31, 2002·Schizophrenia Research·Martin Brüne
Mar 26, 2003·Psychoneuroendocrinology·H Häfner
Apr 18, 2003·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·James T WinslowThomas R Insel
May 3, 2003·The American Journal of Psychiatry·Amy E PinkhamJeffrey Lieberman
Jun 11, 2003·Archives of General Psychiatry·Andre AlemanJean-Paul Selten
Jun 11, 2003·Archives of General Psychiatry·Dolores Malaspina, Eliza Coleman
Jun 13, 2003·The Journal of Head Trauma Rehabilitation·Skye McDonaldJulianne Kinch
Aug 6, 2003·Emotion·John D MayerGill Sitarenios
Mar 30, 2004·CNS Spectrums·Christian G KohlerRuben C Gur
Jul 21, 2004·Psychological Medicine·C D Frith
Sep 29, 2004·Nature Neuroscience·Larry J Young, Zuoxin Wang
Jun 3, 2005·Nature·Michael KosfeldErnst Fehr
Jul 5, 2005·Biological Psychiatry·David I LeitmanDaniel C Javitt
Oct 29, 2005·Schizophrenia Bulletin·Jack J Blanchard, Alex S Cohen
Dec 13, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Peter KirschAndreas Meyer-Lindenberg
Feb 3, 2006·Schizophrenia Bulletin·Raquel E GurRuben C Gur
Mar 17, 2006·Schizophrenia Research·Daphne J HoltGina R Kuperberg
Mar 31, 2006·Cognitive Neuropsychiatry·Leigh HarringtonJohn McClure
Jul 11, 2006·Neuropsychologia·Joel S WinstonRaymond J Dolan
Oct 20, 2006·Journal of Clinical and Experimental Neuropsychology·Paul J MobergBruce I Turetsky
Dec 2, 2006·Biological Psychiatry·Gregor DomesSabine C Herpertz
Dec 5, 2006·Schizophrenia Research·Mark J SergiMichael F Green
Mar 28, 2007·Psychology and Aging·Derek M IsaacowitzPaul T Costa

❮ Previous
Next ❯

Citations

Mar 13, 2018·Current Opinion in Psychiatry·Mary V Seeman, Alexandre González-Rodríguez
Apr 17, 2018·Neuroendocrinology·Yuko MaejimaKenju Shimomura
Nov 28, 2018·Social Cognitive and Affective Neuroscience·Lucas G SpeckChristiane Montag
Dec 7, 2018·Clinical Endocrinology·Raghav BhargavaAled Rees
May 19, 2019·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Lize De CosterJoshua D Woolley
Jul 24, 2020·Journal of Clinical Psychopharmacology·Amir GarakaniRocco F Marotta
Sep 29, 2019·Scientific Reports·Bastian SchillerMarkus Heinrichs
Jun 27, 2018·Therapeutic Delivery·Daniel S QuintanaPer G Djupesland
Sep 29, 2020·The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry·Nina MarshRené Hurlemann
Apr 5, 2019·Psychological Medicine·Ellen R BradleyJoshua D Woolley
Aug 19, 2018·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Shivali KohliKevin C F Fone
Dec 20, 2020·Hormones and Behavior·Ellen R BradleyJoshua D Woolley
Jan 12, 2021·Frontiers in Psychiatry·Amir GarakaniDan V Iosifescu
Mar 7, 2021·International Journal of Molecular Sciences·Kah Kheng GohHsien-Yuan Lane
Mar 16, 2021·Current Behavioral Neuroscience Reports·Marilyn HortaNatalie C Ebner
Mar 31, 2021·Journal of Clinical Psychopharmacology·Robert W BuchananEric Granholm
Nov 28, 2017·Neuroscience and Biobehavioral Reviews·Jack CotterJennifer H Barnett
Jan 4, 2022·Cerebral Cortex·Marie ZeleninaDiana Prata

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
M Mercedes Perez-RodriguezKatherine E Burdick
Pediatric Physical Therapy : the Official Publication of the Section on Pediatrics of the American Physical Therapy Association
Ann F Van Sant
Nursing Management
Kate Gerrish, Ann McMahon
© 2022 Meta ULC. All rights reserved